Charles River Laboratories International Inc (FRA:RV6)
€ 174.9 -0.95 (-0.54%) Market Cap: 9.09 Bil Enterprise Value: 11.58 Bil PE Ratio: 23.14 PB Ratio: 2.51 GF Score: 85/100

Charles River Laboratories International Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2022 / 03:30PM GMT
Release Date Price: €306 (+6.99%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

Hey, good morning everybody. I'm Tycho Peterson from Life Science Team. It's my pleasure to introduce our next company this morning, Charles River Laboratories. Just a quick reminder, if you have questions submit them through the website, and with that I will turn it over to Jim.

James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President

Thank you Tycho, always a pleasure to be at JPMorgan Conference albeit virtually. Should take notice of our Safe Harbor, Reg G and quiet period disclaimer. So we worked on 85% of all the drugs that were approved by FDA last year. Actually 100% of the CNS drugs and 92% of the oncology drugs. We're obviously very proud of those statistics and very proud of the role that we play in the drug development paradigm. We have doubled the size of Charles River over the last 5 years, and we're proud of that as well. We have the #1 position in most of the businesses that we're in, and we have a market in which we are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot